These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6113910)

  • 1. Dose-response studies of quazepam.
    Kales A; Scharf MB; Bixler EO; Schweitzer PK; Jacoby JA; Soldatos CR
    Clin Pharmacol Ther; 1981 Aug; 30(2):194-200. PubMed ID: 6113910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quazepam and flurazepam: long-term use and extended withdrawal.
    Kales A; Bixler EO; Soldatos CR; Vela-Bueno A; Jacoby J; Kales JD
    Clin Pharmacol Ther; 1982 Dec; 32(6):781-8. PubMed ID: 7140142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute effect of quazepam on the sleep of chronic insomniacs. A dose-response study.
    Tietz EI; Roth T; Zorick FJ; Piccione P; Kramer M
    Arzneimittelforschung; 1981; 31(11):1963-6. PubMed ID: 6119098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal.
    Kales A; Bixler EO; Soldatos CR; Vela-Bueno A; Jacoby JA; Kales JD
    Clin Pharmacol Ther; 1986 Mar; 39(3):345-52. PubMed ID: 2868823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quazepam: hypnotic efficacy and side effects.
    Kales A
    Pharmacotherapy; 1990; 10(1):1-10; discussion 10-2. PubMed ID: 1969151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a single dose of quazepam (Sch-16134) on the sleep of chronic insomniacs.
    Roth T; Tietz EI; Kramer M; Kaffeman M
    J Int Med Res; 1979; 7(6):583-7. PubMed ID: 42593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midazolam: dose-response studies of effectiveness and rebound insomnia.
    Kales A; Soldatos CR; Bixler EO; Goff PJ; Vela-Bueno A
    Pharmacology; 1983; 26(3):138-49. PubMed ID: 6132414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
    Scharf MB
    J Clin Psychiatry; 1993 Jan; 54(1):33-8. PubMed ID: 8428895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypnotic effects of low doses of quazepam in older insomniacs.
    Roth TG; Roehrs TA; Koshorek GL; Greenblatt DJ; Rosenthal LD
    J Clin Psychopharmacol; 1997 Oct; 17(5):401-6. PubMed ID: 9315991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective measurements of daytime sleepiness and performance comparing quazepam with flurazepam in two adult populations using the Multiple Sleep Latency Test.
    Dement WC
    J Clin Psychiatry; 1991 Sep; 52 Suppl():31-7. PubMed ID: 1680123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of midazolam on sleep of insomniacs.
    Vogel GW; Vogel F
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):103S-108S. PubMed ID: 6138060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam.
    Kales A; Bixler EO; Vela-Bueno A; Soldatos CR; Niklaus DE; Manfredi RL
    Clin Pharmacol Ther; 1986 Oct; 40(4):378-86. PubMed ID: 3530586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia.
    Ankier SI; Goa KL
    Drugs; 1988 Jan; 35(1):42-62. PubMed ID: 2894293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorazepam-efficacy, side effects, and rebound phenomena.
    Scharf MB; Kales A; Bixler EO; Jacoby JA; Schweitzer PK
    Clin Pharmacol Ther; 1982 Feb; 31(2):175-9. PubMed ID: 6120058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response studies of lormetazepam: efficacy, side effects, and rebound insomnia.
    Kales A; Bixler EO; Soldatos CR; Mitsky DJ; Kales JD
    J Clin Pharmacol; 1982; 22(11-12):520-30. PubMed ID: 6131080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic benzodiazepine usage and withdrawal in insomnia patients.
    Poyares D; Guilleminault C; Ohayon MM; Tufik S
    J Psychiatr Res; 2004; 38(3):327-34. PubMed ID: 15003439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rebound insomnia and elimination half-life: assessment of individual subject response.
    Bixler EO; Kales JD; Kales A; Jacoby JA; Soldatos CR
    J Clin Pharmacol; 1985 Mar; 25(2):115-24. PubMed ID: 2859304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lorazepam: effects on sleep and withdrawal phenomena.
    Kales A; Bixler EO; Soldatos CR; Jacoby JA; Kales JD
    Pharmacology; 1986; 32(3):121-30. PubMed ID: 3960963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics?
    Hohagen F; Montero RF; Weiss E; Lis S; Schönbrunn E; Dressing H; Riemann D; Berger M
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(2):65-72. PubMed ID: 7948056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.